Medical Care
Global Regenerative Medicine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 06, 25
- ID: 288353
- Pages: 163
- Figures: 173
- Views: 3
In 2024, the global market size of Regenerative Medicine was estimated to be worth US$ 47290 million and is forecast to reach approximately US$ 159090 million by 2031 with a CAGR of 19.2% during the forecast period 2025-2031.
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.
The Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering
Segment by Type
Cell Therapy
Tissue Engineering
Biomaterial
Other
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Regenerative Medicine in global and regional level.
Chapter 3: Detailed analysis of Regenerative Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Regenerative Medicine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.
The Regenerative Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering
Segment by Type
Cell Therapy
Tissue Engineering
Biomaterial
Other
Segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Regenerative Medicine in global and regional level.
Chapter 3: Detailed analysis of Regenerative Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Regenerative Medicine revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Regenerative Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Regenerative Medicine Market Size Estimates and Forecasts
2.2 Regenerative Medicine Market Size by Region: 2024 Versus 2031
2.2.1 Global Regenerative Medicine Revenue by Region: 2020-2025
2.2.2 Global Regenerative Medicine Revenue Forecast by Region (2026-2031)
2.2.3 Global Regenerative Medicine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Regenerative Medicine Revenue by Type (2020-2031)
3.1.2 Global Regenerative Medicine Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Regenerative Medicine Revenue by Application (2020-2031)
3.2.2 Global Regenerative Medicine Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Cell Therapy of Regenerative Medicine Revenue Market Share by Application
3.3.2 Tissue Engineering of Regenerative Medicine Revenue Market Share by Application
3.3.3 Biomaterial of Regenerative Medicine Revenue Market Share by Application
3.3.4 Other of Regenerative Medicine Revenue Market Share by Application
4 Global Regenerative Medicine by Company
4.1 Global Regenerative Medicine Revenue by Company (2020-2025)
4.2 Global Regenerative Medicine Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Regenerative Medicine Companies around the World: Ranking by Revenue
4.3.2 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Regenerative Medicine Companies Headquarters & Product Type
4.4.1 Global Regenerative Medicine Companies Headquarters
4.4.2 Date of International Companies Enter into Regenerative Medicine Market
4.4.3 Global Regenerative Medicine Companies Product & Service
4.4.4 Cell Therapy Revenue Market Share of Regenerative Medicine by Company
4.4.5 Tissue Engineering Revenue Market Share of Regenerative Medicine by Company
4.4.6 Biomaterial Revenue Market Share of Regenerative Medicine by Company
4.4.7 Other Revenue Market Share of Regenerative Medicine by Company
4.5 Global Regenerative Medicine Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 J & J (DePuy Synthes)
5.1.1 J & J (DePuy Synthes) Corporation Information
5.1.2 J & J (DePuy Synthes) Description, Business Overview
5.1.3 J & J (DePuy Synthes) Regenerative Medicine Products Offered
5.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.1.5 J & J (DePuy Synthes) Regenerative Medicine Revenue by Product in 2024
5.1.6 J & J (DePuy Synthes) Regenerative Medicine Revenue by Application in 2024
5.1.7 J & J (DePuy Synthes) Regenerative Medicine Revenue by Geographic Area in 2024
5.1.8 J & J (DePuy Synthes) Recent Developments
5.2 Medtronic
5.2.1 Medtronic Corporation Information
5.2.2 Medtronic Description, Business Overview
5.2.3 Medtronic Regenerative Medicine Products Offered
5.2.4 Medtronic Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.2.5 Medtronic Regenerative Medicine Revenue by Product in 2024
5.2.6 Medtronic Regenerative Medicine Revenue by Application in 2024
5.2.7 Medtronic Regenerative Medicine Revenue by Geographic Area in 2024
5.2.8 Medtronic Recent Developments
5.3 Zimmer Biomet
5.3.1 Zimmer Biomet Corporation Information
5.3.2 Zimmer Biomet Description, Business Overview
5.3.3 Zimmer Biomet Regenerative Medicine Products Offered
5.3.4 Zimmer Biomet Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.3.5 Zimmer Biomet Regenerative Medicine Revenue by Product in 2024
5.3.6 Zimmer Biomet Regenerative Medicine Revenue by Application in 2024
5.3.7 Zimmer Biomet Regenerative Medicine Revenue by Geographic Area in 2024
5.3.8 Zimmer Biomet Recent Developments
5.4 Stryker
5.4.1 Stryker Corporation Information
5.4.2 Stryker Description, Business Overview
5.4.3 Stryker Regenerative Medicine Products Offered
5.4.4 Stryker Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.4.5 Stryker Regenerative Medicine Revenue by Product in 2024
5.4.6 Stryker Regenerative Medicine Revenue by Application in 2024
5.4.7 Stryker Regenerative Medicine Revenue by Geographic Area in 2024
5.4.8 Stryker Recent Developments
5.5 Allergan(Acelity)
5.5.1 Allergan(Acelity) Corporation Information
5.5.2 Allergan(Acelity) Description, Business Overview
5.5.3 Allergan(Acelity) Regenerative Medicine Products Offered
5.5.4 Allergan(Acelity) Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.5.5 Allergan(Acelity) Regenerative Medicine Revenue by Product in 2024
5.5.6 Allergan(Acelity) Regenerative Medicine Revenue by Application in 2024
5.5.7 Allergan(Acelity) Regenerative Medicine Revenue by Geographic Area in 2024
5.5.8 Allergan(Acelity) Recent Developments
5.6 MiMedx Group
5.6.1 MiMedx Group Corporation Information
5.6.2 MiMedx Group Description, Business Overview
5.6.3 MiMedx Group Regenerative Medicine Products Offered
5.6.4 MiMedx Group Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.6.5 MiMedx Group Regenerative Medicine Revenue by Product in 2024
5.6.6 MiMedx Group Regenerative Medicine Revenue by Application in 2024
5.6.7 MiMedx Group Regenerative Medicine Revenue by Geographic Area in 2024
5.6.8 MiMedx Group Recent Developments
5.7 Organogenesis
5.7.1 Organogenesis Corporation Information
5.7.2 Organogenesis Description, Business Overview
5.7.3 Organogenesis Regenerative Medicine Products Offered
5.7.4 Organogenesis Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.7.5 Organogenesis Regenerative Medicine Revenue by Product in 2024
5.7.6 Organogenesis Regenerative Medicine Revenue by Application in 2024
5.7.7 Organogenesis Regenerative Medicine Revenue by Geographic Area in 2024
5.7.8 Organogenesis Recent Developments
5.8 Fujifilm Cellular Dynamics
5.8.1 Fujifilm Cellular Dynamics Corporation Information
5.8.2 Fujifilm Cellular Dynamics Description, Business Overview
5.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Products Offered
5.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.8.5 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Product in 2024
5.8.6 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Application in 2024
5.8.7 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Geographic Area in 2024
5.8.8 Fujifilm Cellular Dynamics Recent Developments
5.9 Osiris Therapeutics
5.9.1 Osiris Therapeutics Corporation Information
5.9.2 Osiris Therapeutics Description, Business Overview
5.9.3 Osiris Therapeutics Regenerative Medicine Products Offered
5.9.4 Osiris Therapeutics Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.9.5 Osiris Therapeutics Regenerative Medicine Revenue by Product in 2024
5.9.6 Osiris Therapeutics Regenerative Medicine Revenue by Application in 2024
5.9.7 Osiris Therapeutics Regenerative Medicine Revenue by Geographic Area in 2024
5.9.8 Osiris Therapeutics Recent Developments
5.10 Vcanbio
5.10.1 Vcanbio Corporation Information
5.10.2 Vcanbio Description, Business Overview
5.10.3 Vcanbio Regenerative Medicine Products Offered
5.10.4 Vcanbio Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.10.5 Vcanbio Regenerative Medicine Revenue by Product in 2024
5.10.6 Vcanbio Regenerative Medicine Revenue by Application in 2024
5.10.7 Vcanbio Regenerative Medicine Revenue by Geographic Area in 2024
5.10.8 Vcanbio Recent Developments
5.11 CCBC
5.11.1 CCBC Corporation Information
5.11.2 CCBC Description, Business Overview
5.11.3 CCBC Regenerative Medicine Products Offered
5.11.4 CCBC Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.11.5 CCBC Regenerative Medicine Revenue by Product in 2024
5.11.6 CCBC Regenerative Medicine Revenue by Application in 2024
5.11.7 CCBC Regenerative Medicine Revenue by Geographic Area in 2024
5.11.8 CCBC Recent Developments
5.12 Cytori
5.12.1 Cytori Corporation Information
5.12.2 Cytori Description, Business Overview
5.12.3 Cytori Regenerative Medicine Products Offered
5.12.4 Cytori Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.12.5 Cytori Regenerative Medicine Revenue by Product in 2024
5.12.6 Cytori Regenerative Medicine Revenue by Application in 2024
5.12.7 Cytori Regenerative Medicine Revenue by Geographic Area in 2024
5.12.8 Cytori Recent Developments
5.13 Celgene
5.13.1 Celgene Corporation Information
5.13.2 Celgene Description, Business Overview
5.13.3 Celgene Regenerative Medicine Products Offered
5.13.4 Celgene Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.13.5 Celgene Regenerative Medicine Revenue by Product in 2024
5.13.6 Celgene Regenerative Medicine Revenue by Application in 2024
5.13.7 Celgene Regenerative Medicine Revenue by Geographic Area in 2024
5.13.8 Celgene Recent Developments
5.14 Vericel Corporation
5.14.1 Vericel Corporation Corporation Information
5.14.2 Vericel Corporation Description, Business Overview
5.14.3 Vericel Corporation Regenerative Medicine Products Offered
5.14.4 Vericel Corporation Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.14.5 Vericel Corporation Regenerative Medicine Revenue by Product in 2024
5.14.6 Vericel Corporation Regenerative Medicine Revenue by Application in 2024
5.14.7 Vericel Corporation Regenerative Medicine Revenue by Geographic Area in 2024
5.14.8 Vericel Corporation Recent Developments
5.15 Guanhao Biotech
5.15.1 Guanhao Biotech Corporation Information
5.15.2 Guanhao Biotech Description, Business Overview
5.15.3 Guanhao Biotech Regenerative Medicine Products Offered
5.15.4 Guanhao Biotech Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.15.5 Guanhao Biotech Regenerative Medicine Revenue by Product in 2024
5.15.6 Guanhao Biotech Regenerative Medicine Revenue by Application in 2024
5.15.7 Guanhao Biotech Regenerative Medicine Revenue by Geographic Area in 2024
5.15.8 Guanhao Biotech Recent Developments
5.16 Mesoblast
5.16.1 Mesoblast Corporation Information
5.16.2 Mesoblast Description, Business Overview
5.16.3 Mesoblast Regenerative Medicine Products Offered
5.16.4 Mesoblast Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.16.5 Mesoblast Regenerative Medicine Revenue by Product in 2024
5.16.6 Mesoblast Regenerative Medicine Revenue by Application in 2024
5.16.7 Mesoblast Regenerative Medicine Revenue by Geographic Area in 2024
5.16.8 Mesoblast Recent Developments
5.17 AMAG Pharmaceuticals (CBR)
5.17.1 AMAG Pharmaceuticals (CBR) Corporation Information
5.17.2 AMAG Pharmaceuticals (CBR) Description, Business Overview
5.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Products Offered
5.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.17.5 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Product in 2024
5.17.6 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Application in 2024
5.17.7 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Geographic Area in 2024
5.17.8 AMAG Pharmaceuticals (CBR) Recent Developments
5.18 ViaCord
5.18.1 ViaCord Corporation Information
5.18.2 ViaCord Description, Business Overview
5.18.3 ViaCord Regenerative Medicine Products Offered
5.18.4 ViaCord Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.18.5 ViaCord Regenerative Medicine Revenue by Product in 2024
5.18.6 ViaCord Regenerative Medicine Revenue by Application in 2024
5.18.7 ViaCord Regenerative Medicine Revenue by Geographic Area in 2024
5.18.8 ViaCord Recent Developments
5.19 CordLife
5.19.1 CordLife Corporation Information
5.19.2 CordLife Description, Business Overview
5.19.3 CordLife Regenerative Medicine Products Offered
5.19.4 CordLife Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.19.5 CordLife Regenerative Medicine Revenue by Product in 2024
5.19.6 CordLife Regenerative Medicine Revenue by Application in 2024
5.19.7 CordLife Regenerative Medicine Revenue by Geographic Area in 2024
5.19.8 CordLife Recent Developments
5.20 Integra LifeSciences
5.20.1 Integra LifeSciences Corporation Information
5.20.2 Integra LifeSciences Description, Business Overview
5.20.3 Integra LifeSciences Regenerative Medicine Products Offered
5.20.4 Integra LifeSciences Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.20.5 Integra LifeSciences Regenerative Medicine Revenue by Product in 2024
5.20.6 Integra LifeSciences Regenerative Medicine Revenue by Application in 2024
5.20.7 Integra LifeSciences Regenerative Medicine Revenue by Geographic Area in 2024
5.20.8 Integra LifeSciences Recent Developments
5.21 Nuvasive
5.21.1 Nuvasive Corporation Information
5.21.2 Nuvasive Description, Business Overview
5.21.3 Nuvasive Regenerative Medicine Products Offered
5.21.4 Nuvasive Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.21.5 Nuvasive Regenerative Medicine Revenue by Product in 2024
5.21.6 Nuvasive Regenerative Medicine Revenue by Application in 2024
5.21.7 Nuvasive Regenerative Medicine Revenue by Geographic Area in 2024
5.21.8 Nuvasive Recent Developments
5.22 Cook Biotech
5.22.1 Cook Biotech Corporation Information
5.22.2 Cook Biotech Description, Business Overview
5.22.3 Cook Biotech Regenerative Medicine Products Offered
5.22.4 Cook Biotech Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.22.5 Cook Biotech Regenerative Medicine Revenue by Product in 2024
5.22.6 Cook Biotech Regenerative Medicine Revenue by Application in 2024
5.22.7 Cook Biotech Regenerative Medicine Revenue by Geographic Area in 2024
5.22.8 Cook Biotech Recent Developments
5.23 Japan Tissue Engineering
5.23.1 Japan Tissue Engineering Corporation Information
5.23.2 Japan Tissue Engineering Description, Business Overview
5.23.3 Japan Tissue Engineering Regenerative Medicine Products Offered
5.23.4 Japan Tissue Engineering Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.23.5 Japan Tissue Engineering Regenerative Medicine Revenue by Product in 2024
5.23.6 Japan Tissue Engineering Regenerative Medicine Revenue by Application in 2024
5.23.7 Japan Tissue Engineering Regenerative Medicine Revenue by Geographic Area in 2024
5.23.8 Japan Tissue Engineering Recent Developments
6 North America
6.1 North America Regenerative Medicine Market Size YoY Growth 2020-2031
6.2 North America Regenerative Medicine Market Facts & Figures by Country (2020-2031)
6.3 North America Regenerative Medicine Revenue by Type (2020-2025)
6.4 North America Regenerative Medicine Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Regenerative Medicine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Regenerative Medicine Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Regenerative Medicine Revenue by Type (2020-2025)
7.4 Asia-Pacific Regenerative Medicine Revenue by Application (2020-2025)
8 Europe
8.1 Europe Regenerative Medicine Market Size YoY Growth 2020-2031
8.2 Europe Regenerative Medicine Market Facts & Figures by Country (2020-2031)
8.3 Europe Regenerative Medicine Revenue by Type (2020-2025)
8.4 Europe Regenerative Medicine Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Regenerative Medicine Market Size YoY Growth 2020-2031
9.2 Latin America Regenerative Medicine Market Facts & Figures by Country (2020-2031)
9.3 Latin America Regenerative Medicine Revenue by Type (2020-2025)
9.4 Latin America Regenerative Medicine Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Regenerative Medicine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Regenerative Medicine Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Regenerative Medicine Revenue by Type (2020-2025)
10.4 Middle East and Africa Regenerative Medicine Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Regenerative Medicine Supply Chain Analysis
11.2 Regenerative Medicine Key Raw Materials and Upstream Suppliers
11.3 Regenerative Medicine Clients Analysis
11.4 Regenerative Medicine Sales Channel and Sales Model Analysis
11.4.1 Regenerative Medicine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Regenerative Medicine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Regenerative Medicine Distributors
12 Regenerative Medicine Market Dynamics
12.1 Regenerative Medicine Industry Trends
12.2 Regenerative Medicine Market Drivers
12.3 Regenerative Medicine Market Challenges
12.4 Regenerative Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Regenerative Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Regenerative Medicine Market Size Estimates and Forecasts
2.2 Regenerative Medicine Market Size by Region: 2024 Versus 2031
2.2.1 Global Regenerative Medicine Revenue by Region: 2020-2025
2.2.2 Global Regenerative Medicine Revenue Forecast by Region (2026-2031)
2.2.3 Global Regenerative Medicine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Regenerative Medicine Revenue by Type (2020-2031)
3.1.2 Global Regenerative Medicine Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Regenerative Medicine Revenue by Application (2020-2031)
3.2.2 Global Regenerative Medicine Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Cell Therapy of Regenerative Medicine Revenue Market Share by Application
3.3.2 Tissue Engineering of Regenerative Medicine Revenue Market Share by Application
3.3.3 Biomaterial of Regenerative Medicine Revenue Market Share by Application
3.3.4 Other of Regenerative Medicine Revenue Market Share by Application
4 Global Regenerative Medicine by Company
4.1 Global Regenerative Medicine Revenue by Company (2020-2025)
4.2 Global Regenerative Medicine Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Regenerative Medicine Companies around the World: Ranking by Revenue
4.3.2 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Regenerative Medicine Companies Headquarters & Product Type
4.4.1 Global Regenerative Medicine Companies Headquarters
4.4.2 Date of International Companies Enter into Regenerative Medicine Market
4.4.3 Global Regenerative Medicine Companies Product & Service
4.4.4 Cell Therapy Revenue Market Share of Regenerative Medicine by Company
4.4.5 Tissue Engineering Revenue Market Share of Regenerative Medicine by Company
4.4.6 Biomaterial Revenue Market Share of Regenerative Medicine by Company
4.4.7 Other Revenue Market Share of Regenerative Medicine by Company
4.5 Global Regenerative Medicine Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 J & J (DePuy Synthes)
5.1.1 J & J (DePuy Synthes) Corporation Information
5.1.2 J & J (DePuy Synthes) Description, Business Overview
5.1.3 J & J (DePuy Synthes) Regenerative Medicine Products Offered
5.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.1.5 J & J (DePuy Synthes) Regenerative Medicine Revenue by Product in 2024
5.1.6 J & J (DePuy Synthes) Regenerative Medicine Revenue by Application in 2024
5.1.7 J & J (DePuy Synthes) Regenerative Medicine Revenue by Geographic Area in 2024
5.1.8 J & J (DePuy Synthes) Recent Developments
5.2 Medtronic
5.2.1 Medtronic Corporation Information
5.2.2 Medtronic Description, Business Overview
5.2.3 Medtronic Regenerative Medicine Products Offered
5.2.4 Medtronic Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.2.5 Medtronic Regenerative Medicine Revenue by Product in 2024
5.2.6 Medtronic Regenerative Medicine Revenue by Application in 2024
5.2.7 Medtronic Regenerative Medicine Revenue by Geographic Area in 2024
5.2.8 Medtronic Recent Developments
5.3 Zimmer Biomet
5.3.1 Zimmer Biomet Corporation Information
5.3.2 Zimmer Biomet Description, Business Overview
5.3.3 Zimmer Biomet Regenerative Medicine Products Offered
5.3.4 Zimmer Biomet Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.3.5 Zimmer Biomet Regenerative Medicine Revenue by Product in 2024
5.3.6 Zimmer Biomet Regenerative Medicine Revenue by Application in 2024
5.3.7 Zimmer Biomet Regenerative Medicine Revenue by Geographic Area in 2024
5.3.8 Zimmer Biomet Recent Developments
5.4 Stryker
5.4.1 Stryker Corporation Information
5.4.2 Stryker Description, Business Overview
5.4.3 Stryker Regenerative Medicine Products Offered
5.4.4 Stryker Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.4.5 Stryker Regenerative Medicine Revenue by Product in 2024
5.4.6 Stryker Regenerative Medicine Revenue by Application in 2024
5.4.7 Stryker Regenerative Medicine Revenue by Geographic Area in 2024
5.4.8 Stryker Recent Developments
5.5 Allergan(Acelity)
5.5.1 Allergan(Acelity) Corporation Information
5.5.2 Allergan(Acelity) Description, Business Overview
5.5.3 Allergan(Acelity) Regenerative Medicine Products Offered
5.5.4 Allergan(Acelity) Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.5.5 Allergan(Acelity) Regenerative Medicine Revenue by Product in 2024
5.5.6 Allergan(Acelity) Regenerative Medicine Revenue by Application in 2024
5.5.7 Allergan(Acelity) Regenerative Medicine Revenue by Geographic Area in 2024
5.5.8 Allergan(Acelity) Recent Developments
5.6 MiMedx Group
5.6.1 MiMedx Group Corporation Information
5.6.2 MiMedx Group Description, Business Overview
5.6.3 MiMedx Group Regenerative Medicine Products Offered
5.6.4 MiMedx Group Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.6.5 MiMedx Group Regenerative Medicine Revenue by Product in 2024
5.6.6 MiMedx Group Regenerative Medicine Revenue by Application in 2024
5.6.7 MiMedx Group Regenerative Medicine Revenue by Geographic Area in 2024
5.6.8 MiMedx Group Recent Developments
5.7 Organogenesis
5.7.1 Organogenesis Corporation Information
5.7.2 Organogenesis Description, Business Overview
5.7.3 Organogenesis Regenerative Medicine Products Offered
5.7.4 Organogenesis Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.7.5 Organogenesis Regenerative Medicine Revenue by Product in 2024
5.7.6 Organogenesis Regenerative Medicine Revenue by Application in 2024
5.7.7 Organogenesis Regenerative Medicine Revenue by Geographic Area in 2024
5.7.8 Organogenesis Recent Developments
5.8 Fujifilm Cellular Dynamics
5.8.1 Fujifilm Cellular Dynamics Corporation Information
5.8.2 Fujifilm Cellular Dynamics Description, Business Overview
5.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Products Offered
5.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.8.5 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Product in 2024
5.8.6 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Application in 2024
5.8.7 Fujifilm Cellular Dynamics Regenerative Medicine Revenue by Geographic Area in 2024
5.8.8 Fujifilm Cellular Dynamics Recent Developments
5.9 Osiris Therapeutics
5.9.1 Osiris Therapeutics Corporation Information
5.9.2 Osiris Therapeutics Description, Business Overview
5.9.3 Osiris Therapeutics Regenerative Medicine Products Offered
5.9.4 Osiris Therapeutics Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.9.5 Osiris Therapeutics Regenerative Medicine Revenue by Product in 2024
5.9.6 Osiris Therapeutics Regenerative Medicine Revenue by Application in 2024
5.9.7 Osiris Therapeutics Regenerative Medicine Revenue by Geographic Area in 2024
5.9.8 Osiris Therapeutics Recent Developments
5.10 Vcanbio
5.10.1 Vcanbio Corporation Information
5.10.2 Vcanbio Description, Business Overview
5.10.3 Vcanbio Regenerative Medicine Products Offered
5.10.4 Vcanbio Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.10.5 Vcanbio Regenerative Medicine Revenue by Product in 2024
5.10.6 Vcanbio Regenerative Medicine Revenue by Application in 2024
5.10.7 Vcanbio Regenerative Medicine Revenue by Geographic Area in 2024
5.10.8 Vcanbio Recent Developments
5.11 CCBC
5.11.1 CCBC Corporation Information
5.11.2 CCBC Description, Business Overview
5.11.3 CCBC Regenerative Medicine Products Offered
5.11.4 CCBC Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.11.5 CCBC Regenerative Medicine Revenue by Product in 2024
5.11.6 CCBC Regenerative Medicine Revenue by Application in 2024
5.11.7 CCBC Regenerative Medicine Revenue by Geographic Area in 2024
5.11.8 CCBC Recent Developments
5.12 Cytori
5.12.1 Cytori Corporation Information
5.12.2 Cytori Description, Business Overview
5.12.3 Cytori Regenerative Medicine Products Offered
5.12.4 Cytori Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.12.5 Cytori Regenerative Medicine Revenue by Product in 2024
5.12.6 Cytori Regenerative Medicine Revenue by Application in 2024
5.12.7 Cytori Regenerative Medicine Revenue by Geographic Area in 2024
5.12.8 Cytori Recent Developments
5.13 Celgene
5.13.1 Celgene Corporation Information
5.13.2 Celgene Description, Business Overview
5.13.3 Celgene Regenerative Medicine Products Offered
5.13.4 Celgene Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.13.5 Celgene Regenerative Medicine Revenue by Product in 2024
5.13.6 Celgene Regenerative Medicine Revenue by Application in 2024
5.13.7 Celgene Regenerative Medicine Revenue by Geographic Area in 2024
5.13.8 Celgene Recent Developments
5.14 Vericel Corporation
5.14.1 Vericel Corporation Corporation Information
5.14.2 Vericel Corporation Description, Business Overview
5.14.3 Vericel Corporation Regenerative Medicine Products Offered
5.14.4 Vericel Corporation Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.14.5 Vericel Corporation Regenerative Medicine Revenue by Product in 2024
5.14.6 Vericel Corporation Regenerative Medicine Revenue by Application in 2024
5.14.7 Vericel Corporation Regenerative Medicine Revenue by Geographic Area in 2024
5.14.8 Vericel Corporation Recent Developments
5.15 Guanhao Biotech
5.15.1 Guanhao Biotech Corporation Information
5.15.2 Guanhao Biotech Description, Business Overview
5.15.3 Guanhao Biotech Regenerative Medicine Products Offered
5.15.4 Guanhao Biotech Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.15.5 Guanhao Biotech Regenerative Medicine Revenue by Product in 2024
5.15.6 Guanhao Biotech Regenerative Medicine Revenue by Application in 2024
5.15.7 Guanhao Biotech Regenerative Medicine Revenue by Geographic Area in 2024
5.15.8 Guanhao Biotech Recent Developments
5.16 Mesoblast
5.16.1 Mesoblast Corporation Information
5.16.2 Mesoblast Description, Business Overview
5.16.3 Mesoblast Regenerative Medicine Products Offered
5.16.4 Mesoblast Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.16.5 Mesoblast Regenerative Medicine Revenue by Product in 2024
5.16.6 Mesoblast Regenerative Medicine Revenue by Application in 2024
5.16.7 Mesoblast Regenerative Medicine Revenue by Geographic Area in 2024
5.16.8 Mesoblast Recent Developments
5.17 AMAG Pharmaceuticals (CBR)
5.17.1 AMAG Pharmaceuticals (CBR) Corporation Information
5.17.2 AMAG Pharmaceuticals (CBR) Description, Business Overview
5.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Products Offered
5.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.17.5 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Product in 2024
5.17.6 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Application in 2024
5.17.7 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue by Geographic Area in 2024
5.17.8 AMAG Pharmaceuticals (CBR) Recent Developments
5.18 ViaCord
5.18.1 ViaCord Corporation Information
5.18.2 ViaCord Description, Business Overview
5.18.3 ViaCord Regenerative Medicine Products Offered
5.18.4 ViaCord Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.18.5 ViaCord Regenerative Medicine Revenue by Product in 2024
5.18.6 ViaCord Regenerative Medicine Revenue by Application in 2024
5.18.7 ViaCord Regenerative Medicine Revenue by Geographic Area in 2024
5.18.8 ViaCord Recent Developments
5.19 CordLife
5.19.1 CordLife Corporation Information
5.19.2 CordLife Description, Business Overview
5.19.3 CordLife Regenerative Medicine Products Offered
5.19.4 CordLife Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.19.5 CordLife Regenerative Medicine Revenue by Product in 2024
5.19.6 CordLife Regenerative Medicine Revenue by Application in 2024
5.19.7 CordLife Regenerative Medicine Revenue by Geographic Area in 2024
5.19.8 CordLife Recent Developments
5.20 Integra LifeSciences
5.20.1 Integra LifeSciences Corporation Information
5.20.2 Integra LifeSciences Description, Business Overview
5.20.3 Integra LifeSciences Regenerative Medicine Products Offered
5.20.4 Integra LifeSciences Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.20.5 Integra LifeSciences Regenerative Medicine Revenue by Product in 2024
5.20.6 Integra LifeSciences Regenerative Medicine Revenue by Application in 2024
5.20.7 Integra LifeSciences Regenerative Medicine Revenue by Geographic Area in 2024
5.20.8 Integra LifeSciences Recent Developments
5.21 Nuvasive
5.21.1 Nuvasive Corporation Information
5.21.2 Nuvasive Description, Business Overview
5.21.3 Nuvasive Regenerative Medicine Products Offered
5.21.4 Nuvasive Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.21.5 Nuvasive Regenerative Medicine Revenue by Product in 2024
5.21.6 Nuvasive Regenerative Medicine Revenue by Application in 2024
5.21.7 Nuvasive Regenerative Medicine Revenue by Geographic Area in 2024
5.21.8 Nuvasive Recent Developments
5.22 Cook Biotech
5.22.1 Cook Biotech Corporation Information
5.22.2 Cook Biotech Description, Business Overview
5.22.3 Cook Biotech Regenerative Medicine Products Offered
5.22.4 Cook Biotech Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.22.5 Cook Biotech Regenerative Medicine Revenue by Product in 2024
5.22.6 Cook Biotech Regenerative Medicine Revenue by Application in 2024
5.22.7 Cook Biotech Regenerative Medicine Revenue by Geographic Area in 2024
5.22.8 Cook Biotech Recent Developments
5.23 Japan Tissue Engineering
5.23.1 Japan Tissue Engineering Corporation Information
5.23.2 Japan Tissue Engineering Description, Business Overview
5.23.3 Japan Tissue Engineering Regenerative Medicine Products Offered
5.23.4 Japan Tissue Engineering Regenerative Medicine Revenue and Gross Margin (2020-2025)
5.23.5 Japan Tissue Engineering Regenerative Medicine Revenue by Product in 2024
5.23.6 Japan Tissue Engineering Regenerative Medicine Revenue by Application in 2024
5.23.7 Japan Tissue Engineering Regenerative Medicine Revenue by Geographic Area in 2024
5.23.8 Japan Tissue Engineering Recent Developments
6 North America
6.1 North America Regenerative Medicine Market Size YoY Growth 2020-2031
6.2 North America Regenerative Medicine Market Facts & Figures by Country (2020-2031)
6.3 North America Regenerative Medicine Revenue by Type (2020-2025)
6.4 North America Regenerative Medicine Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Regenerative Medicine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Regenerative Medicine Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Regenerative Medicine Revenue by Type (2020-2025)
7.4 Asia-Pacific Regenerative Medicine Revenue by Application (2020-2025)
8 Europe
8.1 Europe Regenerative Medicine Market Size YoY Growth 2020-2031
8.2 Europe Regenerative Medicine Market Facts & Figures by Country (2020-2031)
8.3 Europe Regenerative Medicine Revenue by Type (2020-2025)
8.4 Europe Regenerative Medicine Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Regenerative Medicine Market Size YoY Growth 2020-2031
9.2 Latin America Regenerative Medicine Market Facts & Figures by Country (2020-2031)
9.3 Latin America Regenerative Medicine Revenue by Type (2020-2025)
9.4 Latin America Regenerative Medicine Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Regenerative Medicine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Regenerative Medicine Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Regenerative Medicine Revenue by Type (2020-2025)
10.4 Middle East and Africa Regenerative Medicine Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Regenerative Medicine Supply Chain Analysis
11.2 Regenerative Medicine Key Raw Materials and Upstream Suppliers
11.3 Regenerative Medicine Clients Analysis
11.4 Regenerative Medicine Sales Channel and Sales Model Analysis
11.4.1 Regenerative Medicine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Regenerative Medicine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Regenerative Medicine Distributors
12 Regenerative Medicine Market Dynamics
12.1 Regenerative Medicine Industry Trends
12.2 Regenerative Medicine Market Drivers
12.3 Regenerative Medicine Market Challenges
12.4 Regenerative Medicine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Regenerative Medicine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Regenerative Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Regenerative Medicine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Regenerative Medicine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Regenerative Medicine Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Regenerative Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 11. Regenerative Medicine Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Regenerative Medicine Players by Revenue (US$ Million) in 2024
Table 13. Global Regenerative Medicine Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2024)
Table 15. Global Regenerative Medicine Companies Headquarters
Table 16. Date of International Companies Enter into Regenerative Medicine Market
Table 17. Global Regenerative Medicine Companies Product & Service
Table 18. Global Regenerative Medicine Mergers & Acquisitions, Expansion Plans
Table 19. J & J (DePuy Synthes) Corporation Information
Table 20. J & J (DePuy Synthes) Description and Business Overview
Table 21. J & J (DePuy Synthes) Regenerative Medicine Product
Table 22. J & J (DePuy Synthes) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. J & J (DePuy Synthes) Revenue Proportion of Regenerative Medicine by Product in 2024
Table 24. J & J (DePuy Synthes) Revenue Proportion of Regenerative Medicine by Application in 2024
Table 25. J & J (DePuy Synthes) Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 26. J & J (DePuy Synthes) Recent Developments
Table 27. Medtronic Corporation Information
Table 28. Medtronic Description and Business Overview
Table 29. Medtronic Regenerative Medicine Product
Table 30. Medtronic Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Medtronic Revenue Proportion of Regenerative Medicine by Product in 2024
Table 32. Medtronic Revenue Proportion of Regenerative Medicine by Application in 2024
Table 33. Medtronic Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 34. Medtronic Recent Developments
Table 35. Zimmer Biomet Corporation Information
Table 36. Zimmer Biomet Description and Business Overview
Table 37. Zimmer Biomet Regenerative Medicine Product
Table 38. Zimmer Biomet Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Zimmer Biomet Revenue Proportion of Regenerative Medicine by Product in 2024
Table 40. Zimmer Biomet Revenue Proportion of Regenerative Medicine by Application in 2024
Table 41. Zimmer Biomet Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 42. Zimmer Biomet Recent Developments
Table 43. Stryker Corporation Information
Table 44. Stryker Description and Business Overview
Table 45. Stryker Regenerative Medicine Product
Table 46. Stryker Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Stryker Revenue Proportion of Regenerative Medicine by Product in 2024
Table 48. Stryker Revenue Proportion of Regenerative Medicine by Application in 2024
Table 49. Stryker Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 50. Stryker Recent Developments
Table 51. Allergan(Acelity) Corporation Information
Table 52. Allergan(Acelity) Description and Business Overview
Table 53. Allergan(Acelity) Regenerative Medicine Product
Table 54. Allergan(Acelity) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Allergan(Acelity) Revenue Proportion of Regenerative Medicine by Product in 2024
Table 56. Allergan(Acelity) Revenue Proportion of Regenerative Medicine by Application in 2024
Table 57. Allergan(Acelity) Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 58. Allergan(Acelity) Recent Developments
Table 59. MiMedx Group Corporation Information
Table 60. MiMedx Group Description and Business Overview
Table 61. MiMedx Group Regenerative Medicine Product
Table 62. MiMedx Group Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. MiMedx Group Revenue Proportion of Regenerative Medicine by Product in 2024
Table 64. MiMedx Group Revenue Proportion of Regenerative Medicine by Application in 2024
Table 65. MiMedx Group Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 66. MiMedx Group Recent Developments
Table 67. Organogenesis Corporation Information
Table 68. Organogenesis Description and Business Overview
Table 69. Organogenesis Regenerative Medicine Product
Table 70. Organogenesis Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Organogenesis Revenue Proportion of Regenerative Medicine by Product in 2024
Table 72. Organogenesis Revenue Proportion of Regenerative Medicine by Application in 2024
Table 73. Organogenesis Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 74. Organogenesis Recent Developments
Table 75. Fujifilm Cellular Dynamics Corporation Information
Table 76. Fujifilm Cellular Dynamics Description and Business Overview
Table 77. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 78. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Fujifilm Cellular Dynamics Revenue Proportion of Regenerative Medicine by Product in 2024
Table 80. Fujifilm Cellular Dynamics Revenue Proportion of Regenerative Medicine by Application in 2024
Table 81. Fujifilm Cellular Dynamics Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 82. Fujifilm Cellular Dynamics Recent Developments
Table 83. Osiris Therapeutics Corporation Information
Table 84. Osiris Therapeutics Description and Business Overview
Table 85. Osiris Therapeutics Regenerative Medicine Product
Table 86. Osiris Therapeutics Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Osiris Therapeutics Revenue Proportion of Regenerative Medicine by Product in 2024
Table 88. Osiris Therapeutics Revenue Proportion of Regenerative Medicine by Application in 2024
Table 89. Osiris Therapeutics Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 90. Osiris Therapeutics Recent Developments
Table 91. Vcanbio Corporation Information
Table 92. Vcanbio Description and Business Overview
Table 93. Vcanbio Regenerative Medicine Product
Table 94. Vcanbio Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Vcanbio Revenue Proportion of Regenerative Medicine by Product in 2024
Table 96. Vcanbio Revenue Proportion of Regenerative Medicine by Application in 2024
Table 97. Vcanbio Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 98. Vcanbio Recent Developments
Table 99. CCBC Corporation Information
Table 100. CCBC Description and Business Overview
Table 101. CCBC Regenerative Medicine Product
Table 102. CCBC Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CCBC Revenue Proportion of Regenerative Medicine by Product in 2024
Table 104. CCBC Revenue Proportion of Regenerative Medicine by Application in 2024
Table 105. CCBC Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 106. CCBC Recent Developments
Table 107. Cytori Corporation Information
Table 108. Cytori Description and Business Overview
Table 109. Cytori Regenerative Medicine Product
Table 110. Cytori Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Cytori Revenue Proportion of Regenerative Medicine by Product in 2024
Table 112. Cytori Revenue Proportion of Regenerative Medicine by Application in 2024
Table 113. Cytori Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 114. Cytori Recent Developments
Table 115. Celgene Corporation Information
Table 116. Celgene Description and Business Overview
Table 117. Celgene Regenerative Medicine Product
Table 118. Celgene Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Celgene Revenue Proportion of Regenerative Medicine by Product in 2024
Table 120. Celgene Revenue Proportion of Regenerative Medicine by Application in 2024
Table 121. Celgene Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 122. Celgene Recent Developments
Table 123. Vericel Corporation Corporation Information
Table 124. Vericel Corporation Description and Business Overview
Table 125. Vericel Corporation Regenerative Medicine Product
Table 126. Vericel Corporation Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Vericel Corporation Revenue Proportion of Regenerative Medicine by Product in 2024
Table 128. Vericel Corporation Revenue Proportion of Regenerative Medicine by Application in 2024
Table 129. Vericel Corporation Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 130. Vericel Corporation Recent Developments
Table 131. Guanhao Biotech Corporation Information
Table 132. Guanhao Biotech Description and Business Overview
Table 133. Guanhao Biotech Regenerative Medicine Product
Table 134. Guanhao Biotech Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Guanhao Biotech Revenue Proportion of Regenerative Medicine by Product in 2024
Table 136. Guanhao Biotech Revenue Proportion of Regenerative Medicine by Application in 2024
Table 137. Guanhao Biotech Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 138. Guanhao Biotech Recent Developments
Table 139. Mesoblast Corporation Information
Table 140. Mesoblast Description and Business Overview
Table 141. Mesoblast Regenerative Medicine Product
Table 142. Mesoblast Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Mesoblast Revenue Proportion of Regenerative Medicine by Product in 2024
Table 144. Mesoblast Revenue Proportion of Regenerative Medicine by Application in 2024
Table 145. Mesoblast Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 146. Mesoblast Recent Developments
Table 147. AMAG Pharmaceuticals (CBR) Corporation Information
Table 148. AMAG Pharmaceuticals (CBR) Description and Business Overview
Table 149. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 150. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. AMAG Pharmaceuticals (CBR) Revenue Proportion of Regenerative Medicine by Product in 2024
Table 152. AMAG Pharmaceuticals (CBR) Revenue Proportion of Regenerative Medicine by Application in 2024
Table 153. AMAG Pharmaceuticals (CBR) Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 154. AMAG Pharmaceuticals (CBR) Recent Developments
Table 155. ViaCord Corporation Information
Table 156. ViaCord Description and Business Overview
Table 157. ViaCord Regenerative Medicine Product
Table 158. ViaCord Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. ViaCord Revenue Proportion of Regenerative Medicine by Product in 2024
Table 160. ViaCord Revenue Proportion of Regenerative Medicine by Application in 2024
Table 161. ViaCord Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 162. ViaCord Recent Developments
Table 163. CordLife Corporation Information
Table 164. CordLife Description and Business Overview
Table 165. CordLife Regenerative Medicine Product
Table 166. CordLife Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. CordLife Revenue Proportion of Regenerative Medicine by Product in 2024
Table 168. CordLife Revenue Proportion of Regenerative Medicine by Application in 2024
Table 169. CordLife Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 170. CordLife Recent Developments
Table 171. Integra LifeSciences Corporation Information
Table 172. Integra LifeSciences Description and Business Overview
Table 173. Integra LifeSciences Regenerative Medicine Product
Table 174. Integra LifeSciences Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Integra LifeSciences Revenue Proportion of Regenerative Medicine by Product in 2024
Table 176. Integra LifeSciences Revenue Proportion of Regenerative Medicine by Application in 2024
Table 177. Integra LifeSciences Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 178. Integra LifeSciences Recent Developments
Table 179. Nuvasive Corporation Information
Table 180. Nuvasive Description and Business Overview
Table 181. Nuvasive Regenerative Medicine Product
Table 182. Nuvasive Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Nuvasive Revenue Proportion of Regenerative Medicine by Product in 2024
Table 184. Nuvasive Revenue Proportion of Regenerative Medicine by Application in 2024
Table 185. Nuvasive Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 186. Nuvasive Recent Developments
Table 187. Cook Biotech Corporation Information
Table 188. Cook Biotech Description and Business Overview
Table 189. Cook Biotech Regenerative Medicine Product
Table 190. Cook Biotech Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 191. Cook Biotech Revenue Proportion of Regenerative Medicine by Product in 2024
Table 192. Cook Biotech Revenue Proportion of Regenerative Medicine by Application in 2024
Table 193. Cook Biotech Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 194. Cook Biotech Recent Developments
Table 195. Japan Tissue Engineering Corporation Information
Table 196. Japan Tissue Engineering Description and Business Overview
Table 197. Japan Tissue Engineering Regenerative Medicine Product
Table 198. Japan Tissue Engineering Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 199. Japan Tissue Engineering Revenue Proportion of Regenerative Medicine by Product in 2024
Table 200. Japan Tissue Engineering Revenue Proportion of Regenerative Medicine by Application in 2024
Table 201. Japan Tissue Engineering Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 202. Japan Tissue Engineering Recent Developments
Table 203. North America Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 204. North America Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 205. North America Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 206. North America Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 207. Asia-Pacific Regenerative Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 208. Asia-Pacific Regenerative Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 209. Asia-Pacific Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 210. Asia-Pacific Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 211. Europe Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 212. Europe Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 213. Europe Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 214. Europe Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 215. Latin America Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 216. Latin America Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 217. Latin America Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 218. Latin America Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 219. Middle East and Africa Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 220. Middle East and Africa Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 221. Middle East and Africa Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 222. Middle East and Africa Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 223. Regenerative Medicine Key Raw Materials, Industry Status and Trend
Table 224. Regenerative Medicine Key Raw Materials and Upstream Suppliers
Table 225. Regenerative Medicine Clients Status and Trend
Table 226. Regenerative Medicine Typical Clients
Table 227. Regenerative Medicine Distributors
Table 228. Regenerative Medicine Market Trends
Table 229. Regenerative Medicine Market Drivers
Table 230. Regenerative Medicine Market Challenges
Table 231. Regenerative Medicine Market Restraints
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Regenerative Medicine Product Picture
Figure 2. Global Regenerative Medicine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Regenerative Medicine Revenue Market Share by Type in 2024 & 2031
Figure 4. Cell Therapy Product Picture
Figure 5. Tissue Engineering Product Picture
Figure 6. Biomaterial Product Picture
Figure 7. Other Product Picture
Figure 8. Global Regenerative Medicine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Regenerative Medicine Revenue Market Share by Application in 2024 & 2031
Figure 10. Dermatology
Figure 11. Cardiovascular
Figure 12. CNS
Figure 13. Orthopedic
Figure 14. Others
Figure 15. Regenerative Medicine Report Years Considered
Figure 16. Global Regenerative Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Regenerative Medicine Market Size (2020-2031) & (US$ Million)
Figure 18. Global Regenerative Medicine Market Size Market Share by Region: 2024 Versus 2031
Figure 19. Global Regenerative Medicine Revenue Market Share by Region (2020-2031)
Figure 20. Global Regenerative Medicine Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Global Regenerative Medicine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Cell Therapy of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 23. Tissue Engineering of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Biomaterial of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Other of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 26. Regenerative Medicine Revenue Share by Company (2024)
Figure 27. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Cell Therapy Revenue Proportion by Company in 2024
Figure 29. Tissue Engineering Revenue Proportion by Company in 2024
Figure 30. Biomaterial Revenue Proportion by Company in 2024
Figure 31. Other Revenue Proportion by Company in 2024
Figure 32. North America Regenerative Medicine Revenue 2020-2031 (US$ Million)
Figure 33. North America Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 34. North America Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Regenerative Medicine Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Regenerative Medicine Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 39. Europe Regenerative Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Regenerative Medicine Revenue Market Share by Country (2020-2031)
Figure 41. Europe Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 42. Europe Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Regenerative Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Regenerative Medicine Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Regenerative Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Regenerative Medicine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 51. Regenerative Medicine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Regenerative Medicine Raw Materials by Region in 2024
Figure 53. Regenerative Medicine Distribution Channels
Figure 54. Global Regenerative Medicine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Regenerative Medicine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Regenerative Medicine Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Regenerative Medicine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Regenerative Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Regenerative Medicine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Regenerative Medicine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Regenerative Medicine Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Regenerative Medicine Revenue by Company (2020-2025) & (US$ Million)
Table 11. Regenerative Medicine Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Regenerative Medicine Players by Revenue (US$ Million) in 2024
Table 13. Global Regenerative Medicine Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2024)
Table 15. Global Regenerative Medicine Companies Headquarters
Table 16. Date of International Companies Enter into Regenerative Medicine Market
Table 17. Global Regenerative Medicine Companies Product & Service
Table 18. Global Regenerative Medicine Mergers & Acquisitions, Expansion Plans
Table 19. J & J (DePuy Synthes) Corporation Information
Table 20. J & J (DePuy Synthes) Description and Business Overview
Table 21. J & J (DePuy Synthes) Regenerative Medicine Product
Table 22. J & J (DePuy Synthes) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. J & J (DePuy Synthes) Revenue Proportion of Regenerative Medicine by Product in 2024
Table 24. J & J (DePuy Synthes) Revenue Proportion of Regenerative Medicine by Application in 2024
Table 25. J & J (DePuy Synthes) Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 26. J & J (DePuy Synthes) Recent Developments
Table 27. Medtronic Corporation Information
Table 28. Medtronic Description and Business Overview
Table 29. Medtronic Regenerative Medicine Product
Table 30. Medtronic Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Medtronic Revenue Proportion of Regenerative Medicine by Product in 2024
Table 32. Medtronic Revenue Proportion of Regenerative Medicine by Application in 2024
Table 33. Medtronic Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 34. Medtronic Recent Developments
Table 35. Zimmer Biomet Corporation Information
Table 36. Zimmer Biomet Description and Business Overview
Table 37. Zimmer Biomet Regenerative Medicine Product
Table 38. Zimmer Biomet Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Zimmer Biomet Revenue Proportion of Regenerative Medicine by Product in 2024
Table 40. Zimmer Biomet Revenue Proportion of Regenerative Medicine by Application in 2024
Table 41. Zimmer Biomet Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 42. Zimmer Biomet Recent Developments
Table 43. Stryker Corporation Information
Table 44. Stryker Description and Business Overview
Table 45. Stryker Regenerative Medicine Product
Table 46. Stryker Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Stryker Revenue Proportion of Regenerative Medicine by Product in 2024
Table 48. Stryker Revenue Proportion of Regenerative Medicine by Application in 2024
Table 49. Stryker Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 50. Stryker Recent Developments
Table 51. Allergan(Acelity) Corporation Information
Table 52. Allergan(Acelity) Description and Business Overview
Table 53. Allergan(Acelity) Regenerative Medicine Product
Table 54. Allergan(Acelity) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Allergan(Acelity) Revenue Proportion of Regenerative Medicine by Product in 2024
Table 56. Allergan(Acelity) Revenue Proportion of Regenerative Medicine by Application in 2024
Table 57. Allergan(Acelity) Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 58. Allergan(Acelity) Recent Developments
Table 59. MiMedx Group Corporation Information
Table 60. MiMedx Group Description and Business Overview
Table 61. MiMedx Group Regenerative Medicine Product
Table 62. MiMedx Group Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. MiMedx Group Revenue Proportion of Regenerative Medicine by Product in 2024
Table 64. MiMedx Group Revenue Proportion of Regenerative Medicine by Application in 2024
Table 65. MiMedx Group Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 66. MiMedx Group Recent Developments
Table 67. Organogenesis Corporation Information
Table 68. Organogenesis Description and Business Overview
Table 69. Organogenesis Regenerative Medicine Product
Table 70. Organogenesis Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Organogenesis Revenue Proportion of Regenerative Medicine by Product in 2024
Table 72. Organogenesis Revenue Proportion of Regenerative Medicine by Application in 2024
Table 73. Organogenesis Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 74. Organogenesis Recent Developments
Table 75. Fujifilm Cellular Dynamics Corporation Information
Table 76. Fujifilm Cellular Dynamics Description and Business Overview
Table 77. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 78. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Fujifilm Cellular Dynamics Revenue Proportion of Regenerative Medicine by Product in 2024
Table 80. Fujifilm Cellular Dynamics Revenue Proportion of Regenerative Medicine by Application in 2024
Table 81. Fujifilm Cellular Dynamics Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 82. Fujifilm Cellular Dynamics Recent Developments
Table 83. Osiris Therapeutics Corporation Information
Table 84. Osiris Therapeutics Description and Business Overview
Table 85. Osiris Therapeutics Regenerative Medicine Product
Table 86. Osiris Therapeutics Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Osiris Therapeutics Revenue Proportion of Regenerative Medicine by Product in 2024
Table 88. Osiris Therapeutics Revenue Proportion of Regenerative Medicine by Application in 2024
Table 89. Osiris Therapeutics Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 90. Osiris Therapeutics Recent Developments
Table 91. Vcanbio Corporation Information
Table 92. Vcanbio Description and Business Overview
Table 93. Vcanbio Regenerative Medicine Product
Table 94. Vcanbio Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Vcanbio Revenue Proportion of Regenerative Medicine by Product in 2024
Table 96. Vcanbio Revenue Proportion of Regenerative Medicine by Application in 2024
Table 97. Vcanbio Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 98. Vcanbio Recent Developments
Table 99. CCBC Corporation Information
Table 100. CCBC Description and Business Overview
Table 101. CCBC Regenerative Medicine Product
Table 102. CCBC Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CCBC Revenue Proportion of Regenerative Medicine by Product in 2024
Table 104. CCBC Revenue Proportion of Regenerative Medicine by Application in 2024
Table 105. CCBC Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 106. CCBC Recent Developments
Table 107. Cytori Corporation Information
Table 108. Cytori Description and Business Overview
Table 109. Cytori Regenerative Medicine Product
Table 110. Cytori Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Cytori Revenue Proportion of Regenerative Medicine by Product in 2024
Table 112. Cytori Revenue Proportion of Regenerative Medicine by Application in 2024
Table 113. Cytori Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 114. Cytori Recent Developments
Table 115. Celgene Corporation Information
Table 116. Celgene Description and Business Overview
Table 117. Celgene Regenerative Medicine Product
Table 118. Celgene Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Celgene Revenue Proportion of Regenerative Medicine by Product in 2024
Table 120. Celgene Revenue Proportion of Regenerative Medicine by Application in 2024
Table 121. Celgene Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 122. Celgene Recent Developments
Table 123. Vericel Corporation Corporation Information
Table 124. Vericel Corporation Description and Business Overview
Table 125. Vericel Corporation Regenerative Medicine Product
Table 126. Vericel Corporation Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Vericel Corporation Revenue Proportion of Regenerative Medicine by Product in 2024
Table 128. Vericel Corporation Revenue Proportion of Regenerative Medicine by Application in 2024
Table 129. Vericel Corporation Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 130. Vericel Corporation Recent Developments
Table 131. Guanhao Biotech Corporation Information
Table 132. Guanhao Biotech Description and Business Overview
Table 133. Guanhao Biotech Regenerative Medicine Product
Table 134. Guanhao Biotech Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Guanhao Biotech Revenue Proportion of Regenerative Medicine by Product in 2024
Table 136. Guanhao Biotech Revenue Proportion of Regenerative Medicine by Application in 2024
Table 137. Guanhao Biotech Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 138. Guanhao Biotech Recent Developments
Table 139. Mesoblast Corporation Information
Table 140. Mesoblast Description and Business Overview
Table 141. Mesoblast Regenerative Medicine Product
Table 142. Mesoblast Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Mesoblast Revenue Proportion of Regenerative Medicine by Product in 2024
Table 144. Mesoblast Revenue Proportion of Regenerative Medicine by Application in 2024
Table 145. Mesoblast Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 146. Mesoblast Recent Developments
Table 147. AMAG Pharmaceuticals (CBR) Corporation Information
Table 148. AMAG Pharmaceuticals (CBR) Description and Business Overview
Table 149. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 150. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. AMAG Pharmaceuticals (CBR) Revenue Proportion of Regenerative Medicine by Product in 2024
Table 152. AMAG Pharmaceuticals (CBR) Revenue Proportion of Regenerative Medicine by Application in 2024
Table 153. AMAG Pharmaceuticals (CBR) Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 154. AMAG Pharmaceuticals (CBR) Recent Developments
Table 155. ViaCord Corporation Information
Table 156. ViaCord Description and Business Overview
Table 157. ViaCord Regenerative Medicine Product
Table 158. ViaCord Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. ViaCord Revenue Proportion of Regenerative Medicine by Product in 2024
Table 160. ViaCord Revenue Proportion of Regenerative Medicine by Application in 2024
Table 161. ViaCord Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 162. ViaCord Recent Developments
Table 163. CordLife Corporation Information
Table 164. CordLife Description and Business Overview
Table 165. CordLife Regenerative Medicine Product
Table 166. CordLife Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. CordLife Revenue Proportion of Regenerative Medicine by Product in 2024
Table 168. CordLife Revenue Proportion of Regenerative Medicine by Application in 2024
Table 169. CordLife Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 170. CordLife Recent Developments
Table 171. Integra LifeSciences Corporation Information
Table 172. Integra LifeSciences Description and Business Overview
Table 173. Integra LifeSciences Regenerative Medicine Product
Table 174. Integra LifeSciences Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 175. Integra LifeSciences Revenue Proportion of Regenerative Medicine by Product in 2024
Table 176. Integra LifeSciences Revenue Proportion of Regenerative Medicine by Application in 2024
Table 177. Integra LifeSciences Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 178. Integra LifeSciences Recent Developments
Table 179. Nuvasive Corporation Information
Table 180. Nuvasive Description and Business Overview
Table 181. Nuvasive Regenerative Medicine Product
Table 182. Nuvasive Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Nuvasive Revenue Proportion of Regenerative Medicine by Product in 2024
Table 184. Nuvasive Revenue Proportion of Regenerative Medicine by Application in 2024
Table 185. Nuvasive Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 186. Nuvasive Recent Developments
Table 187. Cook Biotech Corporation Information
Table 188. Cook Biotech Description and Business Overview
Table 189. Cook Biotech Regenerative Medicine Product
Table 190. Cook Biotech Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 191. Cook Biotech Revenue Proportion of Regenerative Medicine by Product in 2024
Table 192. Cook Biotech Revenue Proportion of Regenerative Medicine by Application in 2024
Table 193. Cook Biotech Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 194. Cook Biotech Recent Developments
Table 195. Japan Tissue Engineering Corporation Information
Table 196. Japan Tissue Engineering Description and Business Overview
Table 197. Japan Tissue Engineering Regenerative Medicine Product
Table 198. Japan Tissue Engineering Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 199. Japan Tissue Engineering Revenue Proportion of Regenerative Medicine by Product in 2024
Table 200. Japan Tissue Engineering Revenue Proportion of Regenerative Medicine by Application in 2024
Table 201. Japan Tissue Engineering Revenue Proportion of Regenerative Medicine by Geographic Area in 2024
Table 202. Japan Tissue Engineering Recent Developments
Table 203. North America Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 204. North America Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 205. North America Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 206. North America Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 207. Asia-Pacific Regenerative Medicine Revenue by Region (2020-2025) & (US$ Million)
Table 208. Asia-Pacific Regenerative Medicine Revenue by Region (2026-2031) & (US$ Million)
Table 209. Asia-Pacific Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 210. Asia-Pacific Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 211. Europe Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 212. Europe Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 213. Europe Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 214. Europe Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 215. Latin America Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 216. Latin America Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 217. Latin America Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 218. Latin America Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 219. Middle East and Africa Regenerative Medicine Revenue by Country (2020-2025) & (US$ Million)
Table 220. Middle East and Africa Regenerative Medicine Revenue by Country (2026-2031) & (US$ Million)
Table 221. Middle East and Africa Regenerative Medicine Revenue by Type (2020-2025) & (US$ Million)
Table 222. Middle East and Africa Regenerative Medicine Revenue by Application (2020-2025) & (US$ Million)
Table 223. Regenerative Medicine Key Raw Materials, Industry Status and Trend
Table 224. Regenerative Medicine Key Raw Materials and Upstream Suppliers
Table 225. Regenerative Medicine Clients Status and Trend
Table 226. Regenerative Medicine Typical Clients
Table 227. Regenerative Medicine Distributors
Table 228. Regenerative Medicine Market Trends
Table 229. Regenerative Medicine Market Drivers
Table 230. Regenerative Medicine Market Challenges
Table 231. Regenerative Medicine Market Restraints
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Regenerative Medicine Product Picture
Figure 2. Global Regenerative Medicine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Regenerative Medicine Revenue Market Share by Type in 2024 & 2031
Figure 4. Cell Therapy Product Picture
Figure 5. Tissue Engineering Product Picture
Figure 6. Biomaterial Product Picture
Figure 7. Other Product Picture
Figure 8. Global Regenerative Medicine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Regenerative Medicine Revenue Market Share by Application in 2024 & 2031
Figure 10. Dermatology
Figure 11. Cardiovascular
Figure 12. CNS
Figure 13. Orthopedic
Figure 14. Others
Figure 15. Regenerative Medicine Report Years Considered
Figure 16. Global Regenerative Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Regenerative Medicine Market Size (2020-2031) & (US$ Million)
Figure 18. Global Regenerative Medicine Market Size Market Share by Region: 2024 Versus 2031
Figure 19. Global Regenerative Medicine Revenue Market Share by Region (2020-2031)
Figure 20. Global Regenerative Medicine Revenue Market Share Forecast by Type (2020-2031)
Figure 21. Global Regenerative Medicine Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Cell Therapy of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 23. Tissue Engineering of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Biomaterial of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 25. Other of Regenerative Medicine Revenue Market Share by Application, 2024 VS 2031
Figure 26. Regenerative Medicine Revenue Share by Company (2024)
Figure 27. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Cell Therapy Revenue Proportion by Company in 2024
Figure 29. Tissue Engineering Revenue Proportion by Company in 2024
Figure 30. Biomaterial Revenue Proportion by Company in 2024
Figure 31. Other Revenue Proportion by Company in 2024
Figure 32. North America Regenerative Medicine Revenue 2020-2031 (US$ Million)
Figure 33. North America Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 34. North America Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Regenerative Medicine Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Regenerative Medicine Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 39. Europe Regenerative Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Regenerative Medicine Revenue Market Share by Country (2020-2031)
Figure 41. Europe Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 42. Europe Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Regenerative Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Regenerative Medicine Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Regenerative Medicine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Regenerative Medicine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Regenerative Medicine Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Regenerative Medicine Revenue Market Share by Application (2020-2025)
Figure 51. Regenerative Medicine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Regenerative Medicine Raw Materials by Region in 2024
Figure 53. Regenerative Medicine Distribution Channels
Figure 54. Global Regenerative Medicine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Regenerative Medicine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232